| Basic Medical Informatin |
| brand name |
| Tegretol |
Razadyne, Razadyne Er, Reminyl, Nivalin |
| Treatment For |
| Seizures And Nerve Pain Such As Trigeminal Neuralgia And Diabetic Neuropathy |
Mild To Moderate Dementia Caused By Alzheimer's Disease |
| Legal Status |
| Rx-only |
Rx-only |
| Pregnancy cat. |
| D (us) |
B (us) |
| Possible Side Effects |
| Dizziness, Drowsiness, Unsteadiness, Nausea And Vomiting |
Diarrhea; Dizziness; Headache; Indigestion; Loss Of Appetite; Mild Stomach Pain Or Upset; Nausea; Tiredness; Trouble Sleeping; Vomiting; Weight Loss. |
| Precautions & Contraindications |
| Increased Eye Pressure, Psychosis, Heart, Kidney, Thyroid Or Liver Diseases, Mood Or Mental Problems, Suicidal Thoughts, Seizures, Pregnancy And Breastfeeding |
Pregnant, Liver Or Kidney Problems, Heart Problems, Unexplained Fainting Episodes, Stomach Or Bowel Problems, Lung Or Breathing Problems, Copd, Or Urinary Blockage Or Trouble Urinating, Brain Lesions Or Tumors, Dementia |
| Excretion |
| 2–3% Excreted Unchanged In Urine |
Renal (95%, Of Which 32% Unchanged), Fecal (5%) |
| Storage Conditions |
| Room Temperature |
Room Temperature, In An Airtight Container. Keep Away From Children |
|
| Dosage, Usage and Forms |
| Forms |
| Tablet |
Tablet, Capsule |
| Routes (of administration) |
| Oral |
Oral |
|
Dosage |
| 200 mg |
|
| Chemical Data |
| Bioavailability |
| 80 % |
80-100% |
| Protein binding |
| 76 % |
Hepatic, 18% |
| Metabolism |
| Hepatic |
Hepatic Partially |
| Half Life (hours) |
| 25-65 H (after Several Doses 12-17 H) |
7 h |
| Formula |
| C15h12n2o |
C17h21no3 |
| Molecular mass (g/mol) |
| 236.269 G/mol |
287.354 G/mol |